Experience
Publications
Read their latest work
Article
Impact of anti-obesity medication coverage in Medicare Part D
06 March 2024 - by Madeleine Cline, Jake K. Klaisner, Ali M. Heinrich, Melanie K. Kuester
How might requiring Part D coverage for anti-obesity medications affect Medicare program costs?
Article
Maximizing opportunities to efficiently manage pharmacy costs in Medicaid
12 January 2023 - by Melanie K. Kuester
As drug costs continue to rise, states need to engage in strategies that include policy and nonpolicy options to manage prescription spending in Medicaid.
Article
Prevalence of rare disease in a commercial population using ICD-10 diagnosis codes
12 August 2022 - by Melanie K. Kuester, Jessica Naber, Conner Smith
Regenerative and targeted therapies increase the need to accurately identify rare diseases, and increased specificity in diagnosis codes of the ICD-10 could help
Article
Moving to a single PDL for a state's Medicaid program
10 January 2020 - by Jill Herbold, Melanie K. Kuester
This paper discusses several decision points and considerations for states evaluating a single preferred drug list requirement.
Article
The effect of a pediatric rare disease on subscriber retention rates for commercial health insurers in the United States
03 October 2018 - by Elizabeth Anne Jackson, Melanie K. Kuester, Brenda Runyan
Insurers, policymakers, and government agencies in the United States may find it useful to have an accurate expectation for the length of enrollment by subscribers with a dependent who suffers from a pediatric rare disease and may be a candidate for a regenerative therapy with a potentially prolonged benefit.
Article
How changing opioid prescribing patterns can impact risk scores
19 April 2018 - by Christine Mytelka, Melanie K. Kuester, Colin R. Gray, Lucas Everheart
This brief provides data on the decline in opioids prescribed to Medicaid expansion populations and the increased use of other non-opioid pain relief drugs.
Article
オピオイドの処方パターンの変化がリスクスコアに与える影響(英語版のみ)
19 April 2018 - by Christine Mytelka, Melanie K. Kuester, Lucas Everheart
本稿は、増加するメディケイド対象者に処方されるオピオイドの減少および他の非オピオイド鎮痛剤の使用増加に関するデータを示すものです。
Article
Incidence rate of females with hemophilia may be underreported
02 June 2017 - by Melanie K. Kuester, Brenda Runyan
Hemophilia, a bleeding disorder, is traditionally known as a condition affecting males. But it’s possible for females to have hemophilia. This paper discusses some reasons why hemophilia may go undiagnosed in women.
Article
血友病を有する女性の発生率が過少報告されている可能性(英語版のみ)
02 June 2017 - by Melanie K. Kuester, Brenda Runyan
出血性疾患である血友病は、伝統的に男性に影響を及ぼす疾患として知られています。しかし、女性も血友病になることがあります。本稿では、なぜ女性の血友病の診断が確定されないのかについて、複数の理由について論じます。